Medegen's Maximus
Medical operating unit develops, manufactures and markets needleless intravenous (IV) therapy products used by leading hospitals across the US.
These products feature the company's patented valve technology, clinically proven to enhance patient
outcomes by assisting in the prevention of bloodstream infections and catheter occlusions.
Maximus is dedicated to providing quality, cost-effective products that meet clinicians' patient care needs, for safety and ease-of-use, as well as ensuring compliance with the needle free regulations.
